{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:31:24Z","timestamp":1780086684608,"version":"3.54.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Homotaurine is a potential therapeutic compound for treatment of Alzheimer\u2019s disease (AD), but its efficacy is still under investigation. Emerging data have shown that other than neuroprotective, homotaurine is endowed with anti-inflammatory activities, though with still unclear underlying mechanisms. Inflammation plays a critical role in the pathogenesis of AD and we previously suggested that homotaurine supplementation in patients with amnestic mild cognitive impairment (MCI) plays beneficial effects associated to a decrease in the circulating levels of the pro-inflammatory cytokine IL-18. Here we report that MCI patients supplemented with homotaurine for 12 months show elevated serum levels of IL-10 and IL-33, as compared to baseline, in addition to the described IL-18 decrease. Furthermore, we observed a significant positive correlation between IL-10 and IL-33 levels after treatment but not at the baseline, underlining the effectiveness of the compound in modulating both cytokines in an inter-related fashion and in regulating the pro\/anti-inflammation balance. Furthermore, the elevation of both IL-10 and IL-33 is significantly associated with an improvement of episodic memory of treated patients, as measured by the Delayed Verbal Ray Test. In conclusion, our results confirm that homotaurine treatment exerts an overall anti-inflammatory action in MCI patients, based not only on the down-regulation of pro-inflammatory IL-18, but also on up-regulation of the anti-inflammatory IL-33 and IL-10 cytokines, which in turn are associated with an amelioration of patient\u2019s cognitive functions. Future studies should be addressed to investigate the molecular mechanisms of homotaurine anti-inflammatory activity and its therapeutic exploitation in early AD.<\/jats:p>","DOI":"10.3389\/fimmu.2022.813951","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:44:54Z","timestamp":1650343494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Elisa","family":"Toppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sireno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerisa","family":"Banaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Golesorkhtafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Spalletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Boss\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a Central Mechanism in Alzheimer\u2019s Disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting Soluble A\u03b2 Peptide With Tramiprosate for the Treatment of Brain Amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol Aging"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in Mild-to-Moderate Alzheimer\u2019s Disease - a Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch Med Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2017.26","article-title":"Clinical Effects of Tramiprosate in Apoe4\/4 Homozygous Patients With Mild Alzheimer\u2019s Disease Suggest Disease Modification Potential","volume":"20174","author":"Abushakra","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0554-0","article-title":"Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 That Inhibits Beta Amyloid Oligomer Formation in the Human Brain","volume":"32","author":"Hey","year":"2018","journal-title":"CNS Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, Gantenerumab, BAN2401, and ALZ-801\u2014the First Wave of Amyloid-Targeting Drugs for Alzheimer\u2019s Disease With Potential for Near Term Approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3275\/8585","article-title":"The Potential Protective Effect of Tramiprosate (Homotaurine) Against Alzheimer\u2019s Disease: A Review","volume":"24","author":"Caltagirone","year":"2012","journal-title":"Aging Clin Exp Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00254","article-title":"Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals","volume":"6","author":"Martorana","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150484","article-title":"Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment","volume":"50","author":"Spalletta","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B10","first-page":"15","article-title":"Effect of Homotaurine in Patients With Cognitive Impairment: Results From an Italian Observational Retrospective Study","volume":"66","author":"Martorana","year":"2018","journal-title":"J Gerontol Geriatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic Cells That Modulate Microglial Activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1038\/s41598-018-32733-3","article-title":"Homotaurine, a Safe Blood-Brain Barrier Permeable GABAA-R-Specific Agonist, Ameliorates Disease in Mouse Models of Multiple Sclerosis","volume":"8","author":"Tian","year":"2018","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4049\/immunohorizons.1900019","article-title":"Homotaurine Treatment Enhances CD4+ and CD8+ Regulatory T Cell Responses and Synergizes With Low-Dose Anti-CD3 to Enhance Diabetes Remission in Type 1 Diabetic Mice","volume":"3","author":"Tian","year":"2019","journal-title":"Immunohorizons"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1038\/s41598-021-84751-3","article-title":"Homotaurine Limits the Spreading of T Cell Autoreactivity Within the CNS and Ameliorates Disease in a Model of Multiple Sclerosis","volume":"11","author":"Tian","year":"2021","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00614","article-title":"A Review on Tramiprosate (Homotaurine) in Alzheimer\u2019s Disease and Other Neurocognitive Disorders","volume":"11","author":"Manzano","year":"2020","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00285","article-title":"Anti-Inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment","volume":"10","author":"Boss\u00f9","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-Inflammatory Interleukin-18 Increases Alzheimer\u2019s Disease-Associated Amyloid-\u03b2 Production in Human Neuron-Like Cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/138161210794519147","article-title":"Interleukin-18, From Neuroinflammation to Alzheimer\u2019s Disease","volume":"16","author":"Boss\u00f9","year":"2010","journal-title":"Curr Pharm Des"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 Family in Innate Inflammation and Acquired Immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604032113","article-title":"IL-33 Ameliorates Alzheimer\u2019s Disease-Like Pathology and Cognitive Decline","volume":"113","author":"Fu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-020-00652-z","article-title":"The Role of Interleukin-33 in Patients With Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"12","author":"Liang","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-020-01806-4","article-title":"IL-33 and its Decoy Sst2 in Patients With Alzheimer\u2019s Disease and Mild Cognitive Impairment","volume":"17","author":"Saresella","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.183","article-title":"IL-33 Promotes IL-10 Production in Macrophages: A Role for IL-33 in Macrophage Foam Cell Formation","volume":"49","author":"Zhang","year":"2017","journal-title":"Exp Mol Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the Immune Response in the Brain: IL-10 and its Regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610297004717","article-title":"Aging, Memory, and Mild Cognitive Impairment","author":"Petersen","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000117297","article-title":"The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment. The Group for the Standardization of the Mental Deterioration Battery","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1037\/h0045106","article-title":"The Serial Position Effect of Free Recall","volume":"64","author":"Murdock","year":"1962","journal-title":"J Exp Psychol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2010.0210","article-title":"Serum and Urinary Levels of IL-18 and its Inhibitor IL-18BP in Systemic Lupus Erythematosus","volume":"21","author":"Migliorini","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.07.005","article-title":"Early and Late CNS Inflammation in Alzheimer\u2019s Disease: Two Extremes of a Continuum","volume":"38","author":"Cuello","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00456","article-title":"A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer\u2019s Disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s Disease: Current Evidence and Future Directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory Markers in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Meta-Analysis and Systematic Review of 170 Studies","volume":"90","author":"Shen","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1010","article-title":"Rey Verbal Learning Test is a Useful Tool for Differential Diagnosis in the Preclinical Phase of Alzheimer\u2019s Disease: Comparison With Mild Cognitive Impairment and Normal Aging","volume":"18","author":"Est\u00e9vez-Gonz\u00e1lez","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.09.005","article-title":"Fractionating Verbal Episodic Memory in Alzheimer\u2019s Disease","volume":"54","author":"Wolk","year":"2011","journal-title":"Neuroimage"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:45:00Z","timestamp":1650343500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2022.813951"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.813951","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"article-number":"813951"}}